Design and Characterization of Spray-Dried Proliposomes for the Pulmonary Delivery of Curcumin-Reference-Cited by-同舟云学术

Design and Characterization of Spray-Dried Proliposomes for the Pulmonary Delivery of Curcumin

Published:2021-04 Issue: Volume:Volume 16 Page:2667-2687
ISSN:1178-2013
Container-title:International Journal of Nanomedicine
language:en
Short-container-title:IJN

Author:

Adel Islam M^ORCID,ElMeligy Mohamed F^ORCID,Abdelrahim Mohamed EA^ORCID,Maged Amr^ORCID,Abdelkhalek AbdelFattah A,Abdelmoteleb Azza MM,Elkasabgy Nermeen A

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,General Medicine,Biomaterials,Bioengineering,Biophysics,Pharmaceutical Science

Reference91 articles.

1. A Review of Curcumin and Its Derivatives as Anticancer Agents

2. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer

3. Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer

4. Inhalation treatment of primary lung cancer using liposomal curcumin dry powder inhalers

5. The Role of Inflammation in the Pathogenesis of Non-small Cell Lung Cancer

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRINZOLAMIDE-LOADED ETHO-LECIPLEX FOR EFFECTIVE OCULAR MANAGEMENT OF GLAUCOMA: D-OPTIMAL DESIGN OPTIMIZATION AND IN VIVO EVALUATION;International Journal of Applied Pharmaceutics;2024-09-07

2. Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides;Journal of Ginseng Research;2024-07

3. “Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: Advances and challenges;Journal of Drug Delivery Science and Technology;2024-06

4. An overview of the efficacy of inhaled curcumin: a new mode of administration for an old molecule;Expert Opinion on Drug Delivery;2024-05-21

5. Development of Paclitaxel Proliposomal Dry Powder Inhaler (PTX-PLM-DPI) by Freeze-Drying Method for Lung Cancer;Drugs and Drug Candidates;2024-03-05